BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 16589350)

  • 1. Alteration of the Kinetic Properties of an Enzyme by the Binding of Buffer, Inhibitor, or Substrate.
    Alberty RA; Bock RM
    Proc Natl Acad Sci U S A; 1953 Sep; 39(9):895-900. PubMed ID: 16589350
    [No Abstract]   [Full Text] [Related]  

  • 2. ITC Methods for Assessing Buffer/Protein Interactions from the Perturbation of Steady-State Kinetics: A Reactivity Study of Homoprotocatechuate 2,3-Dioxygenase.
    Henderson KL; Boyles DK; Le VH; Lewis EA; Emerson JP
    Methods Enzymol; 2016; 567():257-78. PubMed ID: 26794358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic studies on pantothenase from Pseudomonas fluorescens. Effects of pH on substrate and inhibitor binding.
    Airas K
    Biochem J; 1976 Aug; 157(2):415-21. PubMed ID: 9072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inactivation of beta-lactamase I from B. Cereus by dicloxacillin: effect of buffer composition on the kinetic characteristics of the modified enzyme.
    Salifi V; AMicosante G; Strom R
    Ital J Biochem; 1977; 26(1):37-43. PubMed ID: 405348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of NaCl on the kinetic behaviour of mammalian muscle acetylcholinesterase.
    Perez-Guillermo F; Garcia-Carmona F; Garcia-Canovas F; Vidal CJ
    Biochem Int; 1987 Mar; 14(3):385-94. PubMed ID: 3593383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydrodipicolinate synthase from Campylobacter jejuni: kinetic mechanism of cooperative allosteric inhibition and inhibitor-induced substrate cooperativity.
    Skovpen YV; Palmer DR
    Biochemistry; 2013 Aug; 52(32):5454-62. PubMed ID: 23902434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and kinetic mechanism of catalytic domain of human vascular endothelial growth factor receptor-2 tyrosine kinase (VEGFR2 TK), a key enzyme in angiogenesis.
    Parast CV; Mroczkowski B; Pinko C; Misialek S; Khambatta G; Appelt K
    Biochemistry; 1998 Nov; 37(47):16788-801. PubMed ID: 9843450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of inhibitor-resistant natural mutant forms of HIV-1 protease probed by pre-steady state kinetic analysis.
    Zakharova MY; Kuznetsova AA; Kaliberda EN; Dronina MA; Kolesnikov AV; Kozyr AV; Smirnov IV; Rumsh LD; Fedorova OS; Knorre DG; Gabibov AG; Kuznetsov NA
    Biochimie; 2017 Nov; 142():125-134. PubMed ID: 28843613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of Enzyme Kinetic Mechanisms.
    Ulusu NN
    J Mol Evol; 2015 Jun; 80(5-6):251-7. PubMed ID: 25987355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro kinetic properties of the Thr201Met variant of human aromatase gene CYP19A1: functional responses to substrate and product inhibition and enzyme inhibitors.
    Payne EJ; Ingley E; Dick IM; Wilson SG; Bond CS; Prince RL
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2998-3002. PubMed ID: 19470632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evolution of enzyme kinetic power.
    Keleti T; Welch GR
    Biochem J; 1984 Oct; 223(2):299-303. PubMed ID: 6497848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurements of kinetic parameters in a microfluidic reactor.
    Kerby MB; Legge RS; Tripathi A
    Anal Chem; 2006 Dec; 78(24):8273-80. PubMed ID: 17165816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mechanistic kinetic description of lactate dehydrogenase elucidating cancer diagnosis and inhibitor evaluation.
    Tang P; Xu J; Oliveira CL; Li ZJ; Liu S
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):564-571. PubMed ID: 28114833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADAM33 enzyme properties and substrate specificity.
    Zou J; Zhang R; Zhu F; Liu J; Madison V; Umland SP
    Biochemistry; 2005 Mar; 44(11):4247-56. PubMed ID: 15766253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple kinetic method for rapid mechanistic analysis of reversible enzyme inhibitors.
    Lai CJ; Wu JC
    Assay Drug Dev Technol; 2003 Aug; 1(4):527-35. PubMed ID: 15090249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prothrombinase reaction: "mechanism switching" between Michaelis-Menten and non-Michaelis-Menten behaviors.
    Lu Y; Nelsestuen GL
    Biochemistry; 1996 Jun; 35(25):8201-9. PubMed ID: 8679574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human liver sulphamate sulphohydrolase. Determinations of native protein and subunit Mr values and influence of substrate agylcone structure on catalytic properties.
    Freeman C; Hopwood JJ
    Biochem J; 1986 Feb; 234(1):83-92. PubMed ID: 3707548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct Enzyme-Substrate Interactions Revealed by Two Dimensional Kinetic Comparison between Dehaloperoxidase-Hemoglobin and Horseradish Peroxidase.
    Zhao J; Lu C; Franzen S
    J Phys Chem B; 2015 Oct; 119(40):12828-37. PubMed ID: 26375307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and kinetic study of an internal substrate binding site in dehaloperoxidase-hemoglobin A from Amphitrite ornata.
    Zhao J; de Serrano V; Zhao J; Le P; Franzen S
    Biochemistry; 2013 Apr; 52(14):2427-39. PubMed ID: 23480178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical cytochrome p450 kinetics: implications for drug discovery.
    Tracy TS
    Drugs R D; 2006; 7(6):349-63. PubMed ID: 17073518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.